Skip to main content

Table 3 Prescription of cardiovascular medication in family practices in the Netherlands in 2007 (n = 45 family practices; n = 157,137 patients)

From: Primary prevention of cardiovascular diseases: a cost study in family practices

 

in 2005-2007

Prescription cardiovascular medication in 2007

 

Patient group**(n)

Cardio-vascular disease

Diabetes or lipid disorders

Lowest*

(%)

Highest*

(%)

Median

(%)

Mean

(%; n)

 

1

(9,954)

Yes

Yes

75.5

95.6

87.2

87.3

(8,685)

2

(20,976)

Yes

No

49.5

77.2

65.2

64.4

(13,720)

3

(9,287)

No

Yes

15.8

56.1

36.0

36.3

(3,327)

4

(116,920)

No

No

1.0

9.3

3.5

3.9

(4,543)

Total

(157,137)

  

12.0

27.0

19.4

19.2

(30,275)

  1. Notes:
  2. * lowest = family practice with the lowest prescription rate; highest = family practice with the highest prescription rate.
  3. ** patient group 1 = patients with cardiovascular and diabetes (types 1 and 2) and/or disorders of lipid metabolism (e.g. hypercholesterolemia); patient group 2 = patients with cardiovascular disease, but without diabetes or lipid disorders; patient group 3 = patients without cardiovascular disease, but with diabetes or lipid disorders; and patient group 4 = patients with neither cardiovascular nor diabetes or lipid disorders (primary prevention).